BAXANO SURGICAL, INC.
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY13 | FY12 | FY11 | FY10 | FY09 | |
|---|---|---|---|---|---|
| Revenue | $3.1M | $3.8M | $19.2M | $26.2M | $29.8M |
| Operating income | −$31.5M | −$29.7M | −$18.3M | −$20.0M | −$23.6M |
| Net income | −$7.1M | −$5.8M | −$18.3M | −$19.5M | −$23.2M |
| Total assets | $49.0M | $32.3M | $54.0M | $52.0M | — |
| Total liabilities | — | — | — | — | — |
| Equity | $29.4M | $21.1M | $49.5M | $47.7M | $65.3M |
| EPS (diluted) | — | — | — | — | — |
| Shares out. | 27.3M | 27.2M | 27.2M | 20.9M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2013- Operating margin
- −1015.2%
- Net margin
- −229.1%
- Return on equity
- −24.1%
- Return on assets
- −14.5%
- Return on capital (ROCE)
- −83.1%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $1.08
- Revenue growth (YoY)
- −18.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2013- Accruals / assets
- 45.9%high accruals
- Piotroski F-Score
- 1/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 5 warning● 0 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Shapiro James MDirector | Mar 11, 2014 | J | 615 | $0.00 |
| Ainsworth Stephen DOfficer — VP of Research and Development | Jan 2, 2014 | Grant | 54,432 | $0.00 |
| Reali Kenneth MichaelOfficer — President & CEO | Jan 2, 2014 | Grant | 100,000 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Debt acceleration / triggering event · Delisting / listing-standard noticeNov 14, 2014
- Director / officer changeNov 12, 2014
- Director / officer changeOct 31, 2014
- Entered a material agreement · New financial obligation · Unregistered equity saleSep 24, 2014
- Results of operationsAug 5, 2014
- Entered a material agreementJul 14, 2014
- Delisting / listing-standard noticeJun 6, 2014
- Results of operationsMay 8, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/ASCHEDULE 13G (AMENDMENT NO. 3)Feb 10, 2015
- 25FORM 25Nov 24, 2014
- 8-KNov 14, 2014
- 8-KNov 12, 2014
- 8-KOct 31, 2014
- 8-KFORM 8-KSep 24, 2014
- EFFECTAug 22, 2014
- 4OWNERSHIP DOCUMENTAug 19, 2014
- 10-QQUARTERLY REPORTAug 14, 2014
- 8-KFORM 8-KAug 5, 2014
- S-3FORM S-3Jul 31, 2014
- SC 13G/AJul 24, 2014
- 8-KCURRENT REPORTJul 14, 2014
- EFFECTJun 18, 2014
- CORRESPJun 17, 2014